Intracellular and extracellular microRNAs in breast cancer

Clinical Chemistry

Volumn 57, Issue 1, 2011, Pages 18-32

  Corcoran, Claire ^a   Friel, Anne M ^a   Duffy, Michael J ^b   Crown, John ^c   O'Driscoll, Lorraine ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AKLI 5; ALN RSV 01; BEVASIRANIB; MICRORNA; MICRORNA 10B; MICRORNA 125A; MICRORNA 126; MICRORNA 128A; MICRORNA 145; MICRORNA 146; MICRORNA 155; MICRORNA 17; MICRORNA 17 5P; MICRORNA 182; MICRORNA 200B; MICRORNA 205; MICRORNA 206; MICRORNA 21; MICRORNA 224; MICRORNA 27A; MICRORNA 27B; MICRORNA 31; MICRORNA 335; MICRORNA 373; MICRORNA 502C; MICRORNA 96; RNA; RTP 801I 14; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADVANCED CANCER; BIOGENESIS; BREAST CANCER; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MODEL; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL LINE; COLON CARCINOMA; DOWN REGULATION; EXOSOME; EXTRACELLULAR SPACE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; INTRACELLULAR SPACE; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; NONHUMAN; ONCOGENE; PATIENT MONITORING; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SPACE; FEMALE; HUMANS; INTRACELLULAR SPACE; MALE; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650966289     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.150730     Document Type: Review

References (94)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-49.
2. Garcia MJA, Center MM, Hao Y. Siegel RL, Thun MJ. Global cancer facts and figures 2007. Atlanta: American Cancer Society; 2007.
3. Ireland National Cancer Registry. Cancer projections 2005-2035. Cork: National Cancer Registry; 2008. www.ncri.ie/pubs/pubfiles/CancerProjections2010- 2035v4.pdf. (Accessed October 2010).
4. Paranjape T, Slack F, Weidhaas J. MicroRNAs: Tools for cancer diagnostics. Gut 2009;58:1546-54.
5. Germano S, O'Driscoll L. Breast cancer: Understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine. Curr Cancer Drug Targets 2009;9:398-418.
6. Heneghan H, Miller N, Lowery A, Sweeney K, Kerin M. MicroRNAs as novel biomarkers for breast cancer. J Oncol 2010;2010:950201.
7. Lee R, Feinbaum R, Ambros V. The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell 1993; 75:843-54.
8. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk R, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005;120:21-4.
9. Metias S, Lianidou E, Yousef G. MicroRNAs in clinical oncology: At the crossroads between promises and problems. J Clin Pathol 2009;62: 771-6.
10. Hennessy E, O'Driscoll L. Molecular medicine of microRNAs: Structure, function and implications for diabetes. Expert Rev Mol Med 2008;10:e24.
11. Borchert G, Lanier W, Davidson B. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006;13:1097-101.
12. Gregory R, Yan K, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004;432:235-40.
13. Han J, Lee Y, Yeom K, Kim Y, Jin H, Kim V. The drosha-dgcr8 complex in primary microRNA processing. Genes Dev 2004;18:3016-27.
14. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNAse III drosha initiates microRNA processing. Nature 2003;425:415-9.
15. Friedman R, Farh K, Burge C, Bartel D. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
16. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, mir-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32.
17. Zhang B, Pan X, Anderson T. MicroRNA: A new player in stem cells. J Cell Physiol 2006;209: 266-9.
18. Jovanovic M, Hengartner M. MiRNAs and apoptosis: RNAs to die for. Oncogene 2006;25: 6176-87.
19. Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and downregulation of micro-RNA genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
20. Calin G, Croce C. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006; 66:7390-4.
21. Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
22. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6.
23. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
24. Michael M, O' Connor S, van Holst Pellekaan N, Young G, James R. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91.
25. Blenkiron C, Goldstein L, Thorne N, Spiteri I, Chin S, Dunning M, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007;8:R214.
26. Lehmann U, Streichert T, Otto B, Albat C, Hasemeier B, Christgen H, et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010;10:109.
27. Zhang B, Pan X, Cobb G, Anderson T. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12.
28. Manikandan J, Aarthi J, Kumar S, Pushparaj P. Oncomirs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation 2008;2:330-4.
29. Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. Mir-21- mediated tumor growth. Oncogene 2007;26: 2799-803.
30. Frankel L, Christoffersen N, Jacobsen A, Lindow M, Krogh A, Lund A. Programmed cell death 4 (pdcd4) is an important functional target of the microRNA mir-21 in breast cancer cells. J Biol Chem 2008;283:1026-33.
31. Lu Z, Liu M, Stribinskis V, Klinge C, Ramos K, Colburn N, Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008;27:4373-9.
32. Zhu S, Si M, Wu H, Mo Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007;282:14328-36.
33. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob S, Patel T. MicroRNA-21 regulates expression of the pten tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647-58.
34. Song B, Wang C, Liu J, Wang X, Lv L, Wei L, et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 2010; 29:29.
35. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of trail-induced apoptosis pathway. Cancer Res 2007;67:10782-8.
36. Jiang S, Zhang H, Lu M, He X, Li Y, Gu H, et al. MicroRNA-155 functions as an oncomir in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010;70:3119-27.
37. Shi M, Guo N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat Rev 2009; 35:328-34.
38. Mertens-Talcott S, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the g2-m checkpoint in mda-mb-231 breast cancer cells. Cancer Res 2007;67:11001-11.
39. Scott G, Mattie M, Berger C, Benz S, Benz C. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006;66: 1277-81.
40. Guttilla I, White B. Coordinate regulation of foxo1 by mir-27a, mir-96, and mir-182 in breast cancer cells. J Biol Chem 2009;284:23204-16.
41. Spandidos D, Anderson M. Oncogenes and oncosuppressor genes: Their involvement in cancer. J Pathol 1989;157:1-10.
42. Mattie M, Benz C, Bowers J, Sensinger K, Wong L, Scott G, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006;5:24.
43. Scott G, Goga A, Bhaumik D, Berger C, Sullivan C, Benz C. Coordinate suppression of erbb2 and erbb3 by enforced expression of micro-RNA mir- 125a or mir-125b. J Biol Chem 2007;282:1479-86.
44. Guo X, Wu Y, Hartley R. MicroRNA-125a represses cell growth by targeting hur in breast cancer. RNA Biol 2009;6:575-83.
45. Wu H, Zhu S, Mo Y. Suppression of cell growth and invasion by mir-205 in breast cancer. Cell Res 2009;19:439-48.
46. Iorio M, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, et al. MicroRNA-205 regulates her3 in human breast cancer. Cancer Res 2009;69:2195-200.
47. Hayes C, Spink D, Spink B, Cao J, Walker N, Sutter T. 17 beta-estradiol hydroxylation catalyzed by human cytochrome p450 1b1. Proc Natl Acad Sci U S A 1996;93:9776-81.
48. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T. MicroRNA regulates the expression of human cytochrome p450 1b1. Cancer Res 2006; 66:9090-8.
49. Hossain A, Kuo M, Saunders G. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of aib1 mRNA. Mol Cell Biol 2006;26: 8191-201.
50. Yu Z, Wang C, Wang M, Li Z, Casimiro M, Liu M, et al. A cyclin d1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008;182:509-17.
51. Adams B, Furneaux H, White B. The microribonucleic acid (miRNA) mir-206 targets the human estrogen receptor-alpha (eralpha) and represses eralpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007;21:1132-47.
52. Adams B, Cowee D, White B. The role of mir-206 in the epidermal growth factor (egf) induced repression of estrogen receptor-alpha (eralpha) signaling and a luminal phenotype in mcf-7 breast cancer cells. Mol Endocrinol 2009;23:1215-30.
53. Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng L, et al. Mir-145 inhibits breast cancer cell growth through rtkn. Int J Oncol 2009;34:1461-6.
54. Spizzo R, Nicoloso M, Lupini L, Lu Y, Fogarty J, Rossi S, et al. Mir-145 participates with tp53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 2010;17:246-54.
55. Ma L, Teruya-Feldstein J, Weinberg R. Tumour invasion and metastasis initiated by microRNA- 10b in breast cancer. Nature 2007;449:682-8.
56. Gee H, Camps C, Buffa F, Colella S, Sheldon H, Gleadle J, et al. MicroRNA-10b and breast cancer metastasis. Nature 2008;455:E8-9; author reply E9.
57. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs mir-373 and mir-520c promote tumour invasion and metastasis. Nat Cell Biol 2008;10:202-10.
58. Yan L, Huang X, Shao Q, Huang M, Deng L, Wu Q, et al. MicroRNA mir-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008;14:2348-60.
59. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008;18: 350-9.
60. Huang T, Wu F, Loeb G, Hsu R, Heidersbach A, Brincat A, et al. Up-regulation of mir-21 by her2/ neu signaling promotes cell invasion. J Biol Chem 2009;284:18515-24.
61. Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G, et al. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol 2008;10: 593-601.
62. Tryndyak V, Beland F, Pogribny I. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 2010;126: 2575-83.
63. Bhaumik D, Scott G, Schokrpur S, Patil C, Campisi J, Benz C. Expression of microRNA-146 suppresses nf-kappab activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008;27:5643-7.
64. Hurst D, Edmonds M, Scott G, Benz C, Vaidya K, Welch D. Breast cancer metastasis suppressor 1 up-regulates mir-146, which suppresses breast cancer metastasis. Cancer Res 2009;69:1279-83.
65. Tavazoie S, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos P, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-52.
66. Zhu S, Sachdeva M, Wu F, Lu Z, Mo Y. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 2010;29:1763-72.
67. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász A, Wang Z, et al. A pleiotropically acting microRNA, mir-31, inhibits breast cancer metastasis. Cell 2009;137:1032-46.
68. Masri S, Liu Z, Phung S, Wang E, Yuan Y, Chen S. The role of microRNA-128a in regulating tgfbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat 2010;124:89-99.
69. Mei M, Ren Y, Zhou X, Yuan X, Han L, Wang G, et al. Downregulation of mir-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat 2010;9:77-86.
70. Elmore J, Miglioretti D, Reisch L, Barton M, Kreuter W, Christiansen C, Fletcher S. Screening mammograms by community radiologists: Variability in false-positive rates. J Natl Cancer Inst 2002;94:1373-80.
71. Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: A gap analysis. Breast Cancer Res 2008;10:R26.
72. Piccart-Gebhart M, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in her2- positive breast cancer. N Engl J Med 2005;353: 1659-72.
73. Uehara M, Kinoshita T, Hojo T, Akashi-Tanaka S, Iwamoto E, Fukutomi T. Long-term prognostic study of carcinoembryonic antigen (cea) and carbohydrate antigen 15-3 (ca 15-3) in breast cancer. Int J Clin Oncol 2008;13:447-51.
74. O'Driscoll L, Kenny E, Mehta J, Doolan P, Joyce H, Gammell P, et al. Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative rt-pcr. Cancer Genomics Proteomics 2008;5:94-104.
75. Tsang J, Lo Y. Circulating nucleic acids in plasma/ serum. Pathology 2007;39:197-207.
76. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008;3: E3148.
77. Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8.
78. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
79. Xi Y, Nakajima G, Gavin E, Morris C, Kudo K, Hayashi K, Ju J. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007;13:1668-74.
80. Lawrie C, Gal S, Dunlop H, Pushkaran B, Liggins A, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672-5.
81. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse J, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila Pa) 2009;2:807-13.
82. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-26.
83. Ng E, Chong W, Jin H, Lam E, Shin V, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009; 58:1375-81.
84. Zhu W, Qin W, Atasoy U, Sauter E. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009;2:89.
85. Heneghan H, Miller N, Lowery A, Sweeney K, Newell J, Kerin M. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010;251:499-505.
86. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee J, Lötvall J. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9: 654-9.
87. Hunter M, Ismail N, Zhang X, Aguda B, Lee E, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694.
88. Rabinowits G, Gerçel-Taylor C, Day J, Taylor D, Kloecker G. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10:42-6.
89. Taylor D, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13-21.
90. Skog J, Wü rdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-6.
91. Makeyev E, Maniatis T. Multilevel regulation of gene expression by microRNAs. Science (Wash DC) 2008;319:1789-90.
92. Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 2006;34:2294-304.
93. Liu Z, Sall A, Yang D. MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci 2008;9:978-99.
94. Crowder R, Lombardi D, Ellis M. Successful targeting of erbb2 receptors: Is pten the key? Cancer Cell 2004;6:103-4.